0001209191-21-008758.txt : 20210209
0001209191-21-008758.hdr.sgml : 20210209
20210209153746
ACCESSION NUMBER: 0001209191-21-008758
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210209
FILED AS OF DATE: 20210209
DATE AS OF CHANGE: 20210209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vivo Capital VIII, LLC
CENTRAL INDEX KEY: 0001618789
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39988
FILM NUMBER: 21606099
BUSINESS ADDRESS:
STREET 1: 192 LYTTON AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 650 688 0822
MAIL ADDRESS:
STREET 1: 192 LYTTON AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vivo Capital Fund VIII, L.P.
CENTRAL INDEX KEY: 0001618788
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39988
FILM NUMBER: 21606100
BUSINESS ADDRESS:
STREET 1: 505 HAMILTON AVENUE, SUITE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 650 688 0818
MAIL ADDRESS:
STREET 1: 505 HAMILTON AVENUE, SUITE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vivo Capital Surplus Fund VIII, L.P.
CENTRAL INDEX KEY: 0001628048
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39988
FILM NUMBER: 21606101
BUSINESS ADDRESS:
STREET 1: 505 HAMILTON AVENUE, SUITE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 650 688 0818
MAIL ADDRESS:
STREET 1: 505 HAMILTON AVENUE, SUITE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vivo Panda Fund, L.P.
CENTRAL INDEX KEY: 0001675490
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39988
FILM NUMBER: 21606102
BUSINESS ADDRESS:
STREET 1: 575 HIGH STREET, SUITE 201
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 6506880818
MAIL ADDRESS:
STREET 1: 575 HIGH STREET, SUITE 201
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vivo Panda, LLC
CENTRAL INDEX KEY: 0001843847
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39988
FILM NUMBER: 21606103
BUSINESS ADDRESS:
STREET 1: 192 LYTTON AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 650-688-0818
MAIL ADDRESS:
STREET 1: 192 LYTTON AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vivo Opportunity Fund, L.P.
CENTRAL INDEX KEY: 0001726403
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39988
FILM NUMBER: 21606104
BUSINESS ADDRESS:
STREET 1: 192 LYTTON AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 650-688-0818
MAIL ADDRESS:
STREET 1: 192 LYTTON AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vivo Opportunity, LLC
CENTRAL INDEX KEY: 0001728970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39988
FILM NUMBER: 21606105
BUSINESS ADDRESS:
STREET 1: 192 LYTTON AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 6506880818
MAIL ADDRESS:
STREET 1: 192 LYTTON AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bolt Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001641281
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472804636
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-665-9295
MAIL ADDRESS:
STREET 1: 900 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
FORMER COMPANY:
FORMER CONFORMED NAME: Bolt Therapeutics, Inc.
DATE OF NAME CHANGE: 20150504
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-09
0
0001641281
Bolt Biotherapeutics, Inc.
BOLT
0001618789
Vivo Capital VIII, LLC
192 LYTTON AVENUE
PALO ALTO
CA
94301
0
0
1
0
0001618788
Vivo Capital Fund VIII, L.P.
192 LYTTON AVENUE
PALO ALTO
CA
94301
0
0
1
0
0001628048
Vivo Capital Surplus Fund VIII, L.P.
192 LYTTON AVENUE
PALO ALTO
CA
94301
0
0
1
0
0001675490
Vivo Panda Fund, L.P.
192 LYTTON AVENUE
PALO ALTO
CA
94301
0
0
1
0
0001843847
Vivo Panda, LLC
192 LYTTON AVENUE
PALO ALTO
CA
94301
0
0
1
0
0001726403
Vivo Opportunity Fund, L.P.
192 LYTTON AVENUE
PALO ALTO
CA
94301
0
0
1
0
0001728970
Vivo Opportunity, LLC
192 LYTTON AVENUE
PALO ALTO
CA
94301
0
0
1
0
Common Stock
2021-02-09
4
C
0
944056
A
958341
I
By Vivo PANDA Fund, L.P.
Common Stock
2021-02-09
4
C
0
472296
A
1430637
I
By Vivo PANDA Fund, L.P.
Common Stock
2021-02-09
4
X
0
17711
0.07
A
1448348
I
By Vivo PANDA Fund, L.P.
Common Stock
2021-02-09
4
S
0
62
20.00
D
1448286
I
By Vivo PANDA Fund, L.P.
Common Stock
2021-02-09
4
C
0
1092080
A
1117184
I
By Vivo Capital Fund VIII, L.P.
Common Stock
2021-02-09
4
C
0
317922
A
1435106
I
By Vivo Capital Fund VIII, L.P.
Common Stock
2021-02-09
4
C
0
345568
A
1780674
I
By Vivo Capital Fund VIII, L.P.
Common Stock
2021-02-09
4
X
0
40953
0.07
A
1821627
I
By Vivo Capital Fund VIII, L.P.
Common Stock
2021-02-09
4
S
0
144
20.00
D
1821483
I
By Vivo Capital Fund VIII, L.P.
Common Stock
2021-02-09
4
P
0
175733
20.00
A
1997216
I
By Vivo Capital Fund VIII, L.P.
Common Stock
2021-02-09
4
C
0
150802
A
154268
I
By Vivo Capital Surplus Fund VIII, L.P.
Common Stock
2021-02-09
4
C
0
43901
A
198169
I
By Vivo Capital Surplus Fund VIII, L.P.
Common Stock
2021-02-09
4
C
0
47718
A
245887
I
By Vivo Capital Surplus Fund VIII, L.P.
Common Stock
2021-02-09
4
X
0
5655
0.07
A
251542
I
By Vivo Capital Surplus Fund VIII, L.P.
Common Stock
2021-02-09
4
S
0
20
20.00
D
251522
I
By Vivo Capital Surplus Fund VIII, L.P.
Common Stock
2021-02-09
4
P
0
24267
20.00
A
275789
I
By Vivo Capital Surplus Fund VIII, L.P.
Common Stock
2021-02-09
4
P
0
150000
20.00
A
150000
I
By Vivo Opportunity Fund, L.P.
Series A-1 Preferred Stock
2021-02-09
4
C
0
944056
0.00
D
Common Stock
944056
0
I
By Vivo PANDA Fund, L.P.
Series B Preferred Stock
2021-02-09
4
C
0
472296
0.00
D
Common Stock
472296
0
I
By Vivo PANDA Fund, L.P.
Warrant (Right to Buy)
0.07
2021-02-09
4
X
0
17711
0.00
D
2028-07-26
Common Stock
17711
0
I
By Vivo PANDA Fund, L.P.
Series B Preferred Stock
2021-02-09
4
C
0
1092080
0.00
D
Common Stock
1092080
0
I
By Vivo Capital Fund VIII, L.P.
Series C-1 Preferred Stock
2021-02-09
4
C
0
317922
0.00
D
Common Stock
317922
0
I
By Vivo Capital Fund VIII, L.P.
Series C-2 Preferred Stock
2021-02-09
4
C
0
345568
0.00
D
Common Stock
345568
0
I
By Vivo Capital Fund VIII, L.P.
Warrant (Right to Buy)
0.07
2021-02-09
4
X
0
40953
0.00
D
2028-07-26
Common Stock
40953
0
I
By Vivo Capital Fund VIII, L.P.
Series B Preferred Stock
2021-02-09
4
C
0
150802
0.00
D
Common Stock
150802
0
I
By Vivo Capital Surplus Fund VIII, L.P.
Series C-1 Preferred Stock
2021-02-09
4
C
0
43901
0.00
D
Common Stock
43901
0
I
By Vivo Capital Surplus Fund VIII, L.P.
Series C-2 Preferred Stock
2021-02-09
4
C
0
47718
0.00
D
Common Stock
47718
0
I
By Vivo Capital Surplus Fund VIII, L.P.
Warrant (Right to Buy)
0.07
2021-02-09
4
X
0
5655
0.00
D
2028-07-26
Common Stock
5655
0
I
By Vivo Capital Surplus Fund VIII, L.P.
The Series A-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of
the Issuer's initial public offering (the "IPO") and had no expiration date.
The securities reported herein are held of record by Vivo PANDA Fund, L.P. ("Vivo LP"). Vivo Panda, LLC ("Vivo LLC") is the sole general partner of Vivo LP. Mahendra G. Shah, Ph.D. is one of four voting members of Vivo LLC.
The Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date.
Upon closing of the Issuer's IPO, Vivo LP exercised a warrant to purchase 17,711 shares of the Issuer's Common Stock at an exercise price per share of $0.07. Vivo LP paid the exercise price on a cashless basis, resulting in the Issuer withholding 62 share subject to the warrant in order to pay the exercise price and issuing to Vivo LP the remaining 17,649 shares of Common Stock.
The securities reported herein are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC.
The Series C-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date.
The Series C-2 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date.
Upon closing of the Issuer's IPO, Vivo Capital Fund VIII, L.P. exercised a warrant to purchase 40,953 shares of the Issuer's Common Stock at an exercise price per share of $0.07. Vivo Capital Fund VIII, L.P. paid the exercise price on a cashless basis, resulting in the Issuer withholding 144 share subject to the warrant in order to pay the exercise price and issuing to Vivo Capital Fund VIII, L.P. the remaining 40,809 shares of Common Stock.
The securities reported herein are held of record by Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. Edgar Engleman is one of three voting members of Vivo Capital VIII, LLC.
Upon closing of the Issuer's IPO, Vivo Capital Surplus Fund VIII, L.P. exercised a warrant to purchase 5,655 shares of the Issuer's Common Stock at an exercise price per share of $0.07. Vivo Capital Surplus Fund VIII, L.P. paid the exercise price on a cashless basis, resulting in the Issuer withholding 20 share subject to the warrant in order to pay the exercise price and issuing to Vivo Capital Surplus Fund VIII, L.P. the remaining 5,635 shares of Common Stock.
The shares are held of record by Vivo Opportunity Fund, L.P. (VOF). Vivo Opportunity, LLC is the general partner of VOF and has four managing members.
The shares subject to this warrant were fully vested prior to exercise.
Vivo Capital VIII, LLC, By: /s/ Frank Kung, Ph.D., Managing Member
2021-02-09
Vivo Capital Fund VIII, L.P., By: Vivo Capital VIII, LLC, its general partner, By: /s/ Frank Kung, Ph.D., Managing Member
2021-02-09
Vivo Capital Surplus Fund VIII, L.P., By: Vivo Capital VIII, LLC, its general partner, By: /s/ Frank Kung, Ph.D., Managing Member
2021-02-09
Vivo PANDA Fund, L.P., By: Vivo Panda, LLC, its general partner, By: /s/ Mahendra Shah, Ph.D., Managing Member
2021-02-09
Vivo Panda, LLC, By: /s/ Mahendra Shah, Ph.D., Managing Member
2021-02-09
Vivo Opportunity Fund, L.P., By: Vivo Opportunity, LLC, its general partner, By: /s/ Frank Kung, Ph.D., Managing Member
2021-02-09
Vivo Opportunity, LLC, By: /s/ Frank Kung, Ph.D., Managing Member
2021-02-09